Tilray’s stock takes off on hope that cannabis will soon be treated more like steroids than heroin

Tilray’s stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than it is now.